Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bone involvement in Hodgkin's disease

L N Newcomer, M B Silverstein, E C Cadman

    Cancer
    |January 15, 1982
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    STIMULATION OF DIHYDROFOLATE REDUCTASE ACTIVITY BY p-CHLOROMERCURIBENZOATE.

    Biochemical and biophysical research communications·2015
    Same author

    The treatment of disseminated vasculitis with methotrexate.

    Inflammation·2013
    Same author

    Contribution of serine, folate and glycine metabolism to the ATP, NADPH and purine requirements of cancer cells.

    Cell death & disease·2013
    Same author

    Irradiated allogeneic cells enhance umbilical cord blood stem cell engraftment in immunodeficient mice.

    Bone marrow transplantation·2012
    Same author

    Polymerase chain reaction analysis of DNA from paraffin-embedded tissue.

    Methods in molecular biology (Clifton, N.J.)·2011
    Same author

    Manual and automated direct sequencing of product generated by the polymerase chain reaction.

    Methods in molecular biology (Clifton, N.J.)·2011
    Same journal

    Toward exercise as standard care for older cancer survivors.

    Cancer·2026
    Same journal

    Maintenance therapy in gynecologic malignancies: Current and future state.

    Cancer·2026
    Same journal

    Long-term outcomes of evolving treatment regimens in Ewing sarcoma survivors diagnosed 1970-1999: A report from the Childhood Cancer Survivor Study.

    Cancer·2026
    Same journal

    Large-scale osteosarcoma sequencing reveals age-associated genomic architectures.

    Cancer·2026
    Same journal

    EZH2 inhibitor tazemetostat voluntarily withdrawn from market.

    Cancer·2026
    Same journal

    Nivolumab and chemotherapy combination approved for previously untreated Hodgkin lymphoma.

    Cancer·2026
    See all related articles

    Combined-modality therapy shows promising results for advanced Hodgkin

    Area of Science:

    • Oncology
    • Hematology
    • Clinical Medicine

    Background:

    • Advanced-stage or relapsing Hodgkin's disease often presents complex treatment challenges.
    • Osseous involvement in Hodgkin's disease requires specific therapeutic considerations.

    Purpose of the Study:

    • To evaluate the efficacy of combined-modality therapy in patients with Hodgkin's disease and bone involvement.
    • To analyze the characteristics and outcomes of patients with osseous involvement.

    Main Methods:

    • Retrospective analysis of 124 consecutive patients with advanced-stage or relapsing Hodgkin's disease.
    • Identification and characterization of 18 patients with confirmed osseous involvement.
    • Assessment of treatment response and survival rates for patients receiving combined-modality therapy.

    Related Experiment Videos

    Main Results:

    • Eighteen patients (14%) had osseous involvement, with solitary and multiple lesions occurring with similar frequency.
    • Spine and pelvis were the most common sites of bone involvement.
    • Patients with bone lesions demonstrated favorable responses to combined-modality therapy, with a nine-year actuarial survival of 84% and low rates of induction failure and relapse.

    Conclusions:

    • Combined-modality therapy is an effective treatment for Hodgkin's disease with osseous involvement.
    • Patients with bone lesions in Hodgkin's disease can achieve favorable outcomes with current therapeutic approaches.
    • Further investigation into specific treatment strategies for osseous involvement in Hodgkin's disease is warranted.